Cargando…
Teriprizumab-induced myocarditis in a patient with cholangiocarcinoma: a case report
With the extensive use of immune checkpoint inhibitors (ICI) in advanced-stage cancers, immune-related adverse events (irAEs) have been noted in various systems. While most irAEs are reversible and manageable, cardiac toxicities are rare but life-threatening, with high mortality rates. We present a...
Autores principales: | Ye, Yunyao, Li, Yiping, Zhang, Sihui, Han, Gaohua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620143/ https://www.ncbi.nlm.nih.gov/pubmed/36300305 http://dx.doi.org/10.1177/03000605221133259 |
Ejemplares similares
-
Ipilimumab- and nivolumab-induced myocarditis in a patient with metastatic cholangiocarcinoma: a case report
por: Delombaerde, Danielle, et al.
Publicado: (2022) -
Immunotherapy Mechanism of Esophageal Squamous Cell Carcinoma with the Effect of STK11/AMPK Signaling Pathway
por: Xia, Yang, et al.
Publicado: (2022) -
Mesalazine-induced myocarditis: a case report
por: Radhakrishnan, Shiva T., et al.
Publicado: (2018) -
Nivolumab‐induced fatal myocarditis: A case report
por: Bharathidasan, Kavya, et al.
Publicado: (2023) -
Chlamydia Psittaci Pneumonia-Induced Myocarditis: A Case Report
por: Yang, Xiaoming, et al.
Publicado: (2023)